Search Results - "Dagenais, Gilles R"

Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study by Dagenais, Gilles R, Leong, Darryl P, Rangarajan, Sumathy, Lanas, Fernando, Lopez-Jaramillo, Patricio, Gupta, Rajeev, Diaz, Rafael, Avezum, Alvaro, Oliveira, Gustavo B F, Wielgosz, Andreas, Parambath, Shameena R, Mony, Prem, Alhabib, Khalid F, Temizhan, Ahmet, Ismail, Noorhassim, Chifamba, Jephat, Yeates, Karen, Khatib, Rasha, Rahman, Omar, Zatonska, Katarzyna, Kazmi, Khawar, Wei, Li, Zhu, Jun, Rosengren, Annika, Vijayakumar, K, Kaur, Manmeet, Mohan, Viswanathan, Yusufali, AfzalHussein, Kelishadi, Roya, Teo, Koon K, Joseph, Philip, Yusuf, Salim

“…To our knowledge, no previous study has prospectively documented the incidence of common diseases and related mortality in high-income countries (HICs),…”
Get full text

Association between psychosocial work-related factors at midlife and arterial stiffness at older age in a prospective cohort of 1736 white-collar workers by Massamba, Victoria K, Talbot, Denis, Milot, Alain, Trudel, Xavier, Dionne, Clermont E, Vézina, Michel, Mâsse, Benoit, Gilbert-Ouimet, Mahée, Dagenais, Gilles R, Pearce, Neil, Brisson, Chantal

“…Objective Arterial stiffness and exposure to psychosocial work-related factors increase the risk of developing cardiovascular disease. However, little is known…”
Get full text

Job Strain and Risk of Acute Recurrent Coronary Heart Disease Events by Aboa-Éboulé, Corine, Brisson, Chantal, Maunsell, Elizabeth, Mâsse, Benoît, Bourbonnais, Renée, Vézina, Michel, Milot, Alain, Théroux, Pierre, Dagenais, Gilles R

“…CONTEXT There is evidence that job strain increases the risk of a first coronary heart disease (CHD) event. However, little is known about its association with…”
Get full text

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes by Gerstein, Hertzel C., Ramasundarahettige, Chinthanie, Avezum, Alvero, Basile, Jan, Conget, Ignacio, Cushman, William C., Dagenais, Gilles R., Franek, Edward, Lakshmanan, Mark, Lanas, Fernando, Leiter, Lawrence A., Pogosova, Nana, Probstfield, Jeffrey, Raubenheimer, Peter J., Riddle, Matthew, Shaw, Jonathan, Sheu, Wayne H.-H., Temelkova-Kurktschiev, Theodora, Turfanda, Ibrahim, Xavier, Denis

“…Abstract Background The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A…”
Get full text

Time variability of C-reactive protein: implications for clinical risk stratification by Bogaty, Peter, Dagenais, Gilles R, Joseph, Lawrence, Boyer, Luce, Leblanc, Anne, Bélisle, Patrick, Brophy, James M

“…C-reactive protein (CRP) is proposed as a screening test for predicting risk and guiding preventive approaches in coronary artery disease (CAD). However, the…”
Get full text

Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology? by Lemieux, Isabelle, PhD, Poirier, Paul, MD PhD FRCPC FACC FAHA, Bergeron, Jean, MD MSc FRCPC, Alméras, Natalie, PhD, Lamarche, Benoît, PhD FAHA, Cantin, Bernard, MD PhD FRCPC, Dagenais, Gilles R., MD, Després, Jean-Pierre, PhD FAHA

“…The worldwide increase in the prevalence and incidence of type 2 diabetes represents a tremendous challenge for the Canadian health care system, especially if…”
Get full text

Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease by Dagenais, Gilles R., MD, Lu, Jiang, MS, Faxon, David P., MD, Bogaty, Peter, MD, Adler, Dale, MD, Fuentes, Francisco, MD, Escobedo, Jorge, MD, Krishnaswami, Ashok, MD, Slater, James, MD, Frye, Robert L., MD

“…Objectives The purpose of this analysis was to assess in patients with type 2 diabetes and stable coronary artery disease (CAD) whether the risk of all-cause…”
Get full text

Incidental Magnetic Resonance Diffusion-Weighted Imaging–Positive Lesions Are Rare in Neurologically Asymptomatic Community-Dwelling Adults by Batool, Saima, O’Donnell, Martin, Sharma, Mukul, Islam, Shofiqul, Dagenais, Gilles R, Poirier, Paul, Lear, Scott A, Wielgosz, Andreas, Teo, Koon, Stotts, Grant, McCreary, Cheryl R, Frayne, Richard, DeJesus, Jane, Rangarajan, Sumathy, Yusuf, Salim, Smith, Eric E

“…BACKGROUND AND PURPOSE—Incidental magnetic resonance diffusion-weighted imaging (DWI)–positive lesions, considered to represent small acute infarcts, have been…”
Get full text

Effects of Job Strain on Blood Pressure: A Prospective Study of Male and Female White-Collar Workers by Guimont, Chantal, Brisson, Chantal, Dagenais, Gilles R, Milot, Alain, Vezina, Michel, Masse, Benoit, Moisan, Jocelyne, Laflamme, Nathalie, Blanchette, Caty

“…We evaluated whether cumulative exposure to job strain increases blood pressure. A prospective study of 8395 white-collar workers was initiated during 1991 to…”
Get full text

Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk by Sniderman, Allan D., St-Pierre, Annie C., Cantin, Bernard, Dagenais, Gilles R., Després, Jean-Pierre, Lamarche, Benoît

“…The objective of the present study was to examine concordance/discordance among 4 atherogenic indexes of cardiovascular risk: plasma total cholesterol,…”
Get full text

HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study by Després, Jean-Pierre, Lemieux, Isabelle, Dagenais, Gilles-R, Cantin, Bernard, Lamarche, Benoı̂t

“…Background: Primary as well as secondary prevention trials have shown the relevance of lowering LDL-cholesterol to reduce coronary heart disease (CHD) risk…”
Get full text

Effectiveness of a web-based computer-tailored intervention promoting physical activity for adults from Quebec City: a randomized controlled trial by Boudreau, François, Dagenais, Gilles R., de Vries, Hein, Walthouwer, Michel Jean Louis, Côté, José, Turbide, Ginette, Bourlaud, Anne-Sophie, Poirier, Paul

“…The primary objective of this study was to determine the effectiveness of a 3-month web-based computer-tailored intervention on moderate-to-vigorous physical…”
Get full text

Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial by Dagenais, Gilles R, Jung, Hyejung, Lonn, Eva, Bogaty, Peter M, Dehghan, Mahshid, Held, Claes, Avezum, Alvaro, Jansky, Petr, Keltai, Matyàs, Leiter, Lawrence A, Lopez-Jaramillo, Patricio, Toff, William D, Bosch, Jackie, Yusuf, Salim

“…It is not clear whether the effects of lipid-lowering or antihypertensive medications are influenced by adherence to healthy lifestyle factors. We assessed the…”
Get full text

Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification by Kaul, Padma, PhD, David Naylor, C., MD DPhil, Armstrong, Paul W., MD, Mark, Daniel B., MD, Theroux, Pierre, MD, Dagenais, Gilles R., MD

“…Background Despite its widespread use, limited data on the validity of the Canadian Cardiovascular Society angina (CCSA) classification relative to other…”
Get full text

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis by Joseph, Philip, Roshandel, Gholamreza, Gao, Peggy, Pais, Prem, Lonn, Eva, Xavier, Denis, Avezum, Alvaro, Zhu, Jun, Liu, Lisheng, Sliwa, Karen, Gamra, Habib, Bangdiwala, Shrikant I, Teo, Koon, Diaz, Rafael, Dans, Antonio, Lopez-Jaramillo, Patricio, Prabhakaran, Dorairaj, Castellano, Jose Maria, Fuster, Valentin, Rodgers, Anthony, Huffman, Mark D, Bosch, Jackie, Dagenais, Gilles R, Malekzadeh, Reza, Yusuf, Salim

“…In randomised controlled trials, fixed-dose combination treatments (or polypills) have been shown to reduce a composite of cardiovascular disease outcomes in…”
Get full text

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin by Moayyedi, Paul, Eikelboom, John W., Bosch, Jackie, Connolly, Stuart J., Dyal, Leanne, Shestakovska, Olga, Leong, Darryl, Anand, Sonia S., Störk, Stefan, Branch, Kelley R.H., Bhatt, Deepak L., Verhamme, Peter B., O’Donnell, Martin, Maggioni, Aldo P., Lonn, Eva M., Piegas, Leopoldo S., Ertl, Georg, Keltai, Matyas, Bruns, Nancy Cook, Muehlhofer, Eva, Dagenais, Gilles R., Kim, Jae-Hyung, Hori, Masatsugu, Steg, P. Gabriel, Hart, Robert G., Diaz, Rafael, Alings, Marco, Widimsky, Petr, Avezum, Alvaro, Probstfield, Jeffrey, Zhu, Jun, Liang, Yan, Lopez-Jaramillo, Patricio, Kakkar, Ajay K., Parkhomenko, Alexander N., Ryden, Lars, Pogosova, Nana, Dans, Antonio L., Lanas, Fernando, Commerford, Patrick J., Torp-Pedersen, Christian, Guzik, Tomek J., Vinereanu, Dragos, Tonkin, Andrew M., Lewis, Basil S., Felix, Camilo, Yusoff, Khalid, Metsarinne, Kaj P., Fox, Keith A.A., Yusuf, Salim

“…Proton pump inhibitors (PPIs) are effective at treating acid-related disorders. These drugs are well tolerated in the short term, but long-term treatment was…”
Get full text

Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study by Pirro, Matteo, Mauriège, Pascale, Tchernof, André, Cantin, Bernard, Dagenais, Gilles R, Després, Jean-Pierre, Lamarche, Benoı̂t

“…Insulin resistance, through numerous related disturbances in glucose and lipoprotein-lipid metabolism, is associated with an increased risk of ischemic heart…”
Get full text

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial by Moayyedi, Paul, Eikelboom, John W., Bosch, Jackie, Connolly, Stuart J., Dyal, Leanne, Shestakovska, Olga, Leong, Darryl, Anand, Sonia S., Störk, Stefan, Branch, Kelly R.H., Bhatt, Deepak L., Verhamme, Peter B., O’Donnell, Martin, Maggioni, Aldo P., Lonn, Eva M., Piegas, Leopoldo S., Ertl, Georg, Keltai, Matyas, Cook Bruns, Nancy, Muehlhofer, Eva, Dagenais, Gilles R., Kim, Jae-Hyung, Hori, Masatsugu, Steg, P. Gabriel, Hart, Robert G., Diaz, Rafael, Alings, Marco, Widimsky, Petr, Avezum, Alvaro, Probstfield, Jeffrey, Zhu, Jun, Liang, Yan, Lopez-Jaramillo, Patricio, Kakkar, Ajay, Parkhomenko, Alexander N., Ryden, Lars, Pogosova, Nana, Dans, Antonio, Lanas, Fernando, Commerford, Patrick J., Torp-Pedersen, Christian, Guzik, Tomek, Vinereanu, Dragos, Tonkin, Andrew M., Lewis, Basil S., Felix, Camilo, Yusoff, Khalid, Metsarinne, Kaj, Fox, Keith A.A., Yusuf, Salim

“…Antiplatelets and anticoagulants are associated with increased upper gastrointestinal bleeding. We evaluated whether proton pump inhibitor therapy could reduce…”
Get full text

Five-Year Follow-up of the Plaque Sealing With Paclitaxel-Eluting Stents vs Medical Therapy for the Treatment of Intermediate Nonobstructive Saphenous Vein Graft Lesions (VELETI) Trial by Rodés-Cabau, Josep, MD, Bertrand, Olivier F., MD, PhD, Larose, Eric, MD, Déry, Jean-Pierre, MD, Rinfret, Stéphane, MD, Urena, Marina, MD, Jerez, Miguel, MD, Nombela-Franco, Luis, MD, Ribeiro, Henrique B., MD, Allende, Ricardo, MD, Proulx, Guy, MD, Nguyen, Can M., MD, Boudreault, Jean-Rock, MD, Rouleau, Jacques, MD, Roy, Louis, MD, Gleeton, Onil, MD, Barbeau, Gérald, MD, Noël, Bernard, MD, Côté, Mélanie, MSc, Després, Jean-Pierre, PhD, Dagenais, Gilles R., MD, DeLarochellière, Robert, MD

“…Abstract Background Very few data exist on the long-term follow-up of patients with intermediate nonobstructive saphenous vein graft (SVG) lesions. The purpose…”
Get full text

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease by Eikelboom, John W., Bhatt, Deepak L., Fox, Keith A.A., Bosch, Jacqueline, Connolly, Stuart J., Anand, Sonia S., Avezum, Alvaro, Berkowitz, Scott D., Branch, Kelley R.H., Dagenais, Gilles R., Félix, Camilo, Guzik, Tomasz J., Hart, Robert G., Maggioni, Aldo P., Muehlhofer, Eva, Sharma, Mukul, Shestakovska, Olga, Yusuf, Salim

“…The combination of 2.5 mg rivaroxaban twice daily and 100 mg aspirin once daily compared with 100 mg aspirin once daily reduces major adverse cardiovascular…”
Get full text